239 related articles for article (PubMed ID: 3039270)
1. Differences of binding characteristics of non-selective opiates towards mu and delta receptor types.
Delay-Goyet P; Roques BP; Zajac JM
Life Sci; 1987 Aug; 41(6):723-31. PubMed ID: 3039270
[TBL] [Abstract][Full Text] [Related]
2. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
Meunier JC; Kouakou Y; Puget A; Moisand C
Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
[TBL] [Abstract][Full Text] [Related]
3. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
Werling LL; Zarr GD; Brown SR; Cox BM
J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological and anatomical evidence of selective mu, delta, and kappa opioid receptor binding in rat brain.
Mansour A; Lewis ME; Khachaturian H; Akil H; Watson SJ
Brain Res; 1986 Dec; 399(1):69-79. PubMed ID: 3026574
[TBL] [Abstract][Full Text] [Related]
5. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
[TBL] [Abstract][Full Text] [Related]
6. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
[TBL] [Abstract][Full Text] [Related]
7. Modulation of mu, delta and kappa opioid receptors in rat brain by metal ions and histidine.
Tejwani GA; Hanissian SH
Neuropharmacology; 1990 May; 29(5):445-52. PubMed ID: 2162496
[TBL] [Abstract][Full Text] [Related]
8. Differential ontogeny of multiple opioid receptors (mu, delta, and kappa).
Spain JW; Roth BL; Coscia CJ
J Neurosci; 1985 Mar; 5(3):584-8. PubMed ID: 2983043
[TBL] [Abstract][Full Text] [Related]
9. Differential properties of mu and delta opiate binding sites studied with highly selective ligands.
Zajac JM; Roques BP
Life Sci; 1983; 33 Suppl 1():155-8. PubMed ID: 6319853
[TBL] [Abstract][Full Text] [Related]
10. Differences in binding properties of mu and delta opioid receptor subtypes from rat brain: kinetic analysis and effects of ions and nucleotides.
Zajac JM; Roques BP
J Neurochem; 1985 May; 44(5):1605-14. PubMed ID: 2985757
[TBL] [Abstract][Full Text] [Related]
11. The mu-opioid receptor in the 7315c tumor cell.
Tocque B; Jacobson AE; Rice KC; Frey EA
Eur J Pharmacol; 1987 Nov; 143(1):127-30. PubMed ID: 2826184
[TBL] [Abstract][Full Text] [Related]
12. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
Stojilković SS; Dufau ML; Catt KJ
Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
[TBL] [Abstract][Full Text] [Related]
13. Affinity states of rat brain opioid receptors in different tissue preparations.
Zajac JM; Bigeard A; Delay-Goyet P; Roques BP
J Neurochem; 1990 Mar; 54(3):992-9. PubMed ID: 2154555
[TBL] [Abstract][Full Text] [Related]
14. Opioid ligand binding sites in the spinal cord of the guinea-pig.
Zarr GD; Werling LL; Brown SR; Cox BM
Neuropharmacology; 1986 May; 25(5):471-80. PubMed ID: 3016586
[TBL] [Abstract][Full Text] [Related]
15. [3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine.
Nock B; Rajpara A; O'Connor LH; Cicero TJ
Life Sci; 1988; 42(23):2403-12. PubMed ID: 2836684
[TBL] [Abstract][Full Text] [Related]
16. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes.
Werling LL; Brown SR; Puttfarcken P; Cox BM
Mol Pharmacol; 1986 Aug; 30(2):90-5. PubMed ID: 3016504
[TBL] [Abstract][Full Text] [Related]
17. Brain passage of BUBU, a highly selective and potent agonist for delta opioid receptors: in vivo binding and mu versus delta receptors occupancy.
Delay-Goyet P; Ruiz-Gayo M; Baamonde A; Gacel G; Morgat JL; Roques BP
Pharmacol Biochem Behav; 1991 Jan; 38(1):155-62. PubMed ID: 1850135
[TBL] [Abstract][Full Text] [Related]
18. Binding in vivo of selective mu and delta opioid receptor agonists: opioid receptor occupancy by endogenous enkephalins.
Meucci E; Delay-Goyet P; Roques BP; Zajac JM
Eur J Pharmacol; 1989 Nov; 171(2-3):167-78. PubMed ID: 2559856
[TBL] [Abstract][Full Text] [Related]
19. Characterization of high affinity opioid binding sites in rat periaqueductal gray P2 membrane.
Fedynyshyn JP; Kwiat G; Lee NM
Eur J Pharmacol; 1989 Jan; 159(1):83-8. PubMed ID: 2540013
[TBL] [Abstract][Full Text] [Related]
20. Modification by cholecystokinin octapeptide of the binding of mu-, delta-, and kappa-opioid receptors.
Wang XJ; Han JS
J Neurochem; 1990 Oct; 55(4):1379-82. PubMed ID: 2168937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
